Milan 2012 Programme Registration Exhibition Hotels Exhibitor Listing Satellite Meetings Visa Information
Search Abstracts by author or title
(results will display both Free Papers & Poster)

The variation of intraocular pressure of normal and glaucoma patients in case of mild to moderate exercise

Poster Details

First Author: E.Ungureanu ROMANIA

Co Author(s):    S. Gradinaru   A. Stefanescu   O. Palii   D. Dogaru     

Abstract Details



Purpose:

Evaluation of the influence of mild to moderate exercise on intraocular pressure of normal patients and glaucoma patients

Setting:

Prospective study, 32 patients divided in 5 groups, 6-8 patients per group

Methods:

Patients were divided in several groups: normal patients without treatment, normal patients after prostaglandin analogue instilation, normal patients after ?-blocker instilation, glaucoma patients treated with prostaglandin analogue, glaucoma patients treated with ?-blocker. Intraocular pressure was measured before exercise and after, at 1 minute, 15 minutes, 30 minutes and 1 hour. The exercise consisted in submaximal jogging. For a subgroup of normal patients without treatment the exercise consisted in weight lifting.

Results:

Intraocular pressure decreased in all groups except the group with weight lifting where it increased. The decrease was was significant immediately exercise and at 15 minutes; at 30 minutes was significant only in normal patient groups, with or without instillation. For the group with weight lifting most og the patients had an increase of intraocular pressure, which was significant after 15 minutes also.

Conclusions:

Exercise reduces the IOP of glaucoma patients already under antiglaucoma treatment. Moderate aerobic exercise reduces the IOP of healthy individuals. Aerobic exercise also reduces the IOP following instillation of a ?-blocker, a prostaglandin analogue or an ?-agonist. Regular moderate aerobic exercise should be encouraged for glaucoma patients, while weight lifting glaucoma patients should be followed-up carefully FINANCIAL DISCLOSURE?: No

Back to previous

loading Please wait while information is loading.